| scholarly article | Q13442814 |
| P2093 | author name string | Keiser J | |
| Burri C | |||
| P2860 | cites work | Structure-activity and structure-side-effect relationships for the quinolone antibacterials | Q28246405 |
| Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo | Q36042196 | ||
| Human African trypanosomiasis: an emerging public health crisis | Q38887039 | ||
| A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites | Q39085081 | ||
| The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro | Q39416311 | ||
| The molecular biology of trypanosomes | Q40338285 | ||
| Toxicity of quinolone antimicrobial agents | Q40526656 | ||
| Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin | Q41239850 | ||
| Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers. | Q50658451 | ||
| Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy | Q58843955 | ||
| P433 | issue | 5 | |
| P921 | main subject | quinolones | Q426549 |
| P304 | page(s) | 369-389 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Evaluation of quinolone derivatives for antitrypanosomal activity | |
| P478 | volume | 6 |
| Q35685298 | Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions |
| Q38291146 | Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action? |
| Q37925570 | Neglected disease - african sleeping sickness: recent synthetic and modeling advances |
| Q36210891 | Novel antitrypanosomal agents |
| Q37120204 | Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity |
Search more.